152 related articles for article (PubMed ID: 7931045)
1. Development of novel thrombolytic agents.
Collen D; De Bono DP; Lijnen HR; Pannekoek H
J Intern Med; 1994 Oct; 236(4):433-7. PubMed ID: 7931045
[No Abstract] [Full Text] [Related]
2. [New thrombolytic agents].
Okada K
Rinsho Byori; 1992 Mar; Suppl 92():115-30. PubMed ID: 1583770
[No Abstract] [Full Text] [Related]
3. The acyl-enzymes and pro-urokinase: promising new thrombolytic agents.
Samama M; Horellou MH; Nguyen G; Conard J
Haemostasis; 1986; 16 Suppl 3():33-7. PubMed ID: 3095196
[No Abstract] [Full Text] [Related]
4. Pharmacology of thrombolytic drugs.
Verstraete M; Collen D
J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):33B-40B. PubMed ID: 3097100
[TBL] [Abstract][Full Text] [Related]
5. The search for the ideal thrombolytic agent.
Verstraete M
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of fibrinolysis.
Haire WD
Chest; 1992 Apr; 101(4 Suppl):91S-97S. PubMed ID: 1555484
[TBL] [Abstract][Full Text] [Related]
7. [New thrombolytic agents].
Nguyen G; Samama M
Ann Biol Clin (Paris); 1987; 45(2):212-8. PubMed ID: 3113300
[TBL] [Abstract][Full Text] [Related]
8. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
Gurewich V; Pannell R
Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
[No Abstract] [Full Text] [Related]
9. [Thrombolytics and their use].
Alessi MC; Juhan-Vague I
Rev Prat; 1999 Oct; 49(15):1654-8. PubMed ID: 10581996
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of thrombolytic therapy.
Lijnen HR; Collen D
Haemostasis; 1986; 16 Suppl 3():3-15. PubMed ID: 2945766
[No Abstract] [Full Text] [Related]
11. [Effect of thrombolytic agents on infarct size and left ventricle systolic function in myocardial infarction].
Bassand JP; Cassagnes J; Machecourt J; Anguenot T; Lusson JR; Borel E; Schiele F; Wolf JF; Vachet D
Arch Mal Coeur Vaiss; 1990 Feb; 83 Spec No 1():31-6. PubMed ID: 2108644
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic agents.
Thompson PL
Med J Aust; 1994 Jan; 160(1):29-32. PubMed ID: 8271981
[No Abstract] [Full Text] [Related]
13. [A hybrid molecule of pro-urokinase and a fibrin-specific, monoclonal antibody fragment is a more effective thrombolytic agent than pro-urokinase in vitro and in vivo].
Bode C; Eberle T; Runge M; Haber E; Kübler W
Verh Dtsch Ges Inn Med; 1990; 96():1-3. PubMed ID: 2128723
[No Abstract] [Full Text] [Related]
14. Thrombolytic therapy and equivalence trials.
White HD
J Am Coll Cardiol; 1998 Mar; 31(3):494-6. PubMed ID: 9502625
[No Abstract] [Full Text] [Related]
15. [Acyl enzymes and pro-urokinase: promising new thrombolytic agents].
Samama M; Horellou MH; Nguyen G; Conard J
Haemostasis; 1986; 16 Suppl 4():35-9. PubMed ID: 3095199
[No Abstract] [Full Text] [Related]
16. Which thrombolytic agent should one choose?
Topol EJ
Prog Cardiovasc Dis; 1991; 34(3):165-78. PubMed ID: 1947122
[No Abstract] [Full Text] [Related]
17. Thrombolytic agents in development.
Verstraete M; Lijnen HR; Collen D
Drugs; 1995 Jul; 50(1):29-42. PubMed ID: 7588087
[TBL] [Abstract][Full Text] [Related]
18. Fibrinolytic agents.
Schmitz-Huebner U; van de Loo J
Clin Haematol; 1981 Jun; 10(2):481-96. PubMed ID: 7032785
[No Abstract] [Full Text] [Related]
19. Synergism of thrombolytic agents: investigational procedures and clinical potential.
Collen D
Circulation; 1988 Apr; 77(4):731-5. PubMed ID: 3127075
[No Abstract] [Full Text] [Related]
20. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
Bachmann F
Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
